Centessa Pharmaceuticals (CNTA) Enterprise Value (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Enterprise Value of -$276.6 million for Q1 2026, up 2.78% year-over-year from -$269.1 million in Q1 2025, and up 6.11% on a QoQ basis from -$294.6 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 7 years of Enterprise Value data on file, last reported at -$276.6 million in Q1 2026.
- Quarterly Enterprise Value rose 2.78% year-over-year to -$276.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$276.6 million (up 2.78% YoY) and the FY2025 annual result came in at -$294.6 million, up 38.91% from the prior year.
- Enterprise Value grew to -$276.6 million in Q1 2026 per CNTA's latest filing, from -$294.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$230.2 million in Q1 2024 and bottomed at -$544.5 million in Q1 2022.
- The 5-year median for Enterprise Value is -$294.8 million (2024), against an average of -$349.0 million.
- The widest annual swing landed in 2024, when Enterprise Value sank 87.95%; it then soared 52.51% in 2025.
- Tracing CNTA's Enterprise Value over 5 years: stood at -$393.6 million in 2022, then soared by 34.83% to -$256.5 million in 2023, then slumped by 87.95% to -$482.2 million in 2024, then jumped by 38.91% to -$294.6 million in 2025, then climbed by 6.11% to -$276.6 million in 2026.
- Per Business Quant, the three latest CNTA Enterprise Value figures stand at -$276.6 million (Q1 2026), -$294.6 million (Q4 2025), and -$246.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | -276.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -276.59 Mn |
| Dec 31, 2025 | -294.58 Mn |
| Sep 30, 2025 | -246.21 Mn |
| Jun 30, 2025 | -250.72 Mn |
| Mar 31, 2025 | -284.51 Mn |
| Dec 31, 2024 | -482.18 Mn |
| Sep 30, 2024 | -518.45 Mn |
| Jun 30, 2024 | -294.83 Mn |
| Mar 31, 2024 | -230.18 Mn |
| Dec 31, 2023 | -256.55 Mn |
| Sep 30, 2023 | -281.34 Mn |
| Jun 30, 2023 | -303.59 Mn |
| Mar 31, 2023 | -346.23 Mn |
| Dec 31, 2022 | -393.64 Mn |
| Sep 30, 2022 | -444.80 Mn |
| Jun 30, 2022 | -484.16 Mn |
| Mar 31, 2022 | -544.50 Mn |
| Dec 31, 2021 | -595.08 Mn |
| Sep 30, 2021 | -578.82 Mn |
| Jun 30, 2021 | -613.80 Mn |
| Dec 31, 2020 | -7.23 Mn |